Microbiome testing analyzes the DNA of bacteria, fungi, and other microorganisms living in your gut (or other body sites) to produce a profile of what’s there and in what proportions. Most commercial tests use a stool sample you collect at home, which is then processed in a lab using DNA sequencing technology. The result is a detailed breakdown of your microbial community, including which species are present, how diverse they are, and sometimes what functions those microbes may be performing.
How the Testing Works
All microbiome tests rely on DNA sequencing, but there are two fundamentally different approaches. The first, called 16S sequencing, targets a single gene that all bacteria share. It amplifies that gene from your sample and uses the small variations in it to identify which bacterial groups are present. This method is cost-effective and widely used, but it has a ceiling: it can usually identify bacteria only down to the genus level (a broad category), not the exact species. It also misses non-bacterial members of your microbiome like fungi, viruses, and parasites entirely, since they don’t carry this gene.
The second approach, shotgun metagenomic sequencing, reads all the DNA in your sample indiscriminately. This gives a much sharper picture. It can identify microbes down to the species level and detect fungi, viruses, and other organisms that 16S misses. It also reveals the functional genes those microbes carry, offering clues about what they’re actually doing, like producing short-chain fatty acids or breaking down fiber. The tradeoff is cost: shotgun sequencing requires far more data per sample and is more expensive to run.
A comparative study in Frontiers in Microbiology found that at the genus level, only about 26% of all genera detected were picked up by both methods. Each approach has blind spots the other covers, which means your results can look quite different depending on which technology a company uses.
Collecting Your Sample at Home
Most direct-to-consumer tests ship you a kit with collection tools and a preservative solution. You collect a small amount of stool, place it into a tube containing a stabilizing liquid (which prevents bacterial DNA from degrading during transit), and mail it back at room temperature. The process is straightforward and typically takes a few minutes. Samples generally need to reach the lab within a few days of collection to maintain quality.
One important detail: your gut microbiome shifts naturally from day to day based on what you’ve eaten, how you’ve slept, medications, and other factors. A reproducibility study found that when the same person’s stool was sampled on different days, the correlation between results was 0.68 on a scale where 1.0 means identical. That’s noticeably lower than the near-perfect correlation (0.94) seen when the same sample was processed multiple times in the lab. In practical terms, this means the lab work itself is reliable, but your microbiome on a Monday may look somewhat different from your microbiome on a Thursday. A single test is a snapshot, not a permanent portrait.
What Your Results Show
A typical report includes several layers of information. The most prominent is a list of microbial species or genera found in your sample, along with their relative abundance (what percentage of your total community each one represents). You might see, for example, that a bacterium associated with gut lining health makes up 0.9% of your community, while another linked to fiber digestion accounts for 12%.
Reports also commonly include diversity scores. “Alpha diversity” measures how many different types of microbes live in your gut and how evenly they’re distributed. Higher diversity is generally associated with better health outcomes. “Beta diversity” compares your microbial profile to other people’s profiles, showing how similar or different your gut community is relative to a reference population.
Some tests go further and flag specific organisms of interest. For instance, a species called Akkermansia muciniphila has been linked to lower obesity risk and better metabolic health. Data from the American Gut Project found the median abundance of this bacterium was just 0.08% across participants, though levels varied enormously from person to person. Many reports will tell you where you fall on this spectrum compared to their database of other users. Higher-end tests using shotgun sequencing may also report on functional pathways, telling you whether your microbial community carries genes involved in producing vitamins, metabolizing certain drugs, or generating inflammation-related compounds.
What Microbiome Testing Can and Can’t Tell You
The promise of microbiome testing is appealing: learn what’s living in your gut and use that information to improve your health. And there is genuine science behind the concept. Researchers have identified gut microbial signatures associated with conditions ranging from inflammatory bowel disease to obesity to type 2 diabetes. A 2024 study in Nature Medicine developed a microbiome-based diagnostic model for inflammatory bowel disease that achieved accuracy scores above 0.90 in initial testing and held up across multiple ethnic populations. For ulcerative colitis specifically, the bacterial biomarker panel outperformed fecal calprotectin, a standard clinical marker, in distinguishing inactive disease from healthy controls.
But there’s a significant gap between what researchers can do with microbiome data in controlled studies and what a consumer test can reliably tell you at home. The biggest limitation is that science hasn’t yet established firm “healthy ranges” for most gut bacteria. Unlike a blood test where a cholesterol level above a certain number has clear clinical meaning, there’s no consensus on what your optimal level of any given microbe should be. Your results might show you have less of a particular species than the company’s reference population, but that comparison depends heavily on who else is in their database.
Regulatory Oversight Is Minimal
Most commercial microbiome tests are not FDA-cleared diagnostic tools. They’re marketed as general wellness products, which places them in a regulatory gray area. A 2024 analysis in the Journal of Law and the Biosciences found significant gaps in oversight: these tests lack the standardized proficiency testing required of clinical laboratory tests, and the FDA has largely treated them as low-risk wellness products exempt from medical device regulation. The authors noted that consumers likely believe these tests are FDA-regulated when they are not.
This matters because companies can make broad claims about what your results mean and offer dietary or supplement recommendations based on your profile, all without the level of evidence the FDA would require for a medical test. Some of those recommendations may be helpful (eating more fiber is rarely bad advice), but others may be ineffective or, in rare cases, counterproductive. The regulatory analysis specifically flagged the risk that some test recommendations “may be harmful to their health, or, at a minimum, are ineffective and a waste of money.”
Who Benefits Most From Testing
For people with chronic digestive symptoms that haven’t been explained by standard medical workups, microbiome testing can offer additional data points to discuss with a gastroenterologist, particularly one who specializes in the microbiome. It can also be useful for tracking changes over time: if you’re making significant dietary shifts or recovering from a course of antibiotics, sequential tests can show whether your microbial diversity is rebounding.
For generally healthy people curious about their gut, the test results are interesting but often not actionable in ways that go beyond standard nutrition advice. Most reports will suggest eating more plant-based fiber, fermented foods, and a diverse diet. These are solid recommendations, but you don’t need a $200 test to arrive at them. Where testing becomes more valuable is when it identifies something specific, like a very low diversity score, an unusual dominance by a single bacterial group, or the presence of a known pathogenic organism. These findings can prompt meaningful conversations with a healthcare provider and more targeted interventions.